A clinical predictive model for post-hospitalisation venous thromboembolism in patients with inflammatory bowel disease

被引:33
|
作者
McCurdy, Jeffrey D. [1 ,2 ]
Israel, Amanda [1 ]
Hasan, Maryam [1 ]
Weng, Robin [1 ]
Mallick, Ranjeeta [2 ]
Ramsay, Tim [2 ]
Carrier, Marc [2 ,3 ]
机构
[1] Ottawa Hosp, Div Gastroenterol, Ottawa, ON, Canada
[2] Ottawa Hosp, Ottawa Hosp Res Inst, Ottawa, ON, Canada
[3] Ottawa Hosp, Div Hematol, Ottawa, ON, Canada
关键词
MEDICAL PATIENTS; ULCERATIVE-COLITIS; RISK-FACTORS; THROMBOPROPHYLAXIS; PROPHYLAXIS; THROMBOSIS; DURATION; EVENTS; EPIDEMIOLOGY; METAANALYSIS;
D O I
10.1111/apt.15286
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Patients with inflammatory bowel disease (IBD) are at increased risk of venous thromboembolism (VTE) during hospitalisation and potentially post-discharge. Aims To determine the incidence and risk factors for post-discharge VTE in IBD patients and create a point of care predictive model to assess VTE risk. Methods Hospitalised IBD patients were identified from our institutional discharge database between 2009 and 2016, and were assessed for VTE by chart review. Risk factors for VTE within 3 months of discharge were determined by univariable and multivariable logistic regression. A point of care model was created using variables from the univariate analysis with P < 0.05, and internally validated by bootstrap methods. Results Sixty-six of 2161 eligible discharges (3%) were associated with VTE within 6 months of hospitalisation. The median time to event was 37 days (range 3-182 days). On multivariable analysis age >45 years (OR 3.76; 95% CI 1.80-7.89) and multiple admissions (OR 2.62; 95% CI 1.34-5.11) were independently associated with VTE risk. Our final model incorporated age >45 years, multiple admissions, intensive care unit admission, length of admission >7 days and central catheter and was able to discriminate between discharges associated with and without VTE (optimism-corrected c-statistic, 0.70; 95% CI 0.58-0.77). By limiting treatment to a high-risk group, extended thromboprophylaxis could be avoided in 92% of discharges with a miss rate of 1.6% (32/1982 discharges). Conclusion Patients with IBD remain at risk of VTE after hospital discharge. Our model may help clinicians stratify which patients will benefit most from extended thrombophrophylaxis.
引用
收藏
页码:1493 / 1501
页数:9
相关论文
共 50 条
  • [1] The risk of venous thromboembolism during and after hospitalisation in patients with inflammatory bowel disease activity
    Chu, Thomas P. C.
    Grainge, Matthew J.
    Card, Timothy R.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (10) : 1099 - 1108
  • [2] Venous Thromboembolism in Patients with Inflammatory Bowel Disease
    Dhaliwal, Galvin
    Patrone, Michael V.
    Bickston, Stephen J.
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (01)
  • [3] Clinical presentation of venous thromboembolism in inflammatory bowel disease
    Papay, Pavol
    Miehsler, Wolfgang
    Tilg, Herbert
    Petritsch, Wolfgang
    Reinisch, Walter
    Mayer, Andreas
    Haas, Thomas
    Kaser, Arthur
    Feichtenschlager, Thomas
    Fuchssteiner, Harry
    Knoflach, Peter
    Vogelsang, Harald
    Platzer, Reingard
    Tillinger, Wolfgang
    Jaritz, Bernhard
    Schmid, Alfons
    Blaha, Benedikt
    Dejaco, Clemens
    Sobala, Anna
    Weltermann, Ansgar
    Eichinger, Sabine
    Novacek, Gottfried
    JOURNAL OF CROHNS & COLITIS, 2013, 7 (09): : 723 - 729
  • [4] Preventability of Venous Thromboembolism in Patients with Inflammatory Bowel Disease
    Scoville, Elizabeth
    Konijeti, Gauree
    Yajnik, Vijay
    Nguyen, Deanna
    Sauk, Jenny
    Ananthakrishnan, Ashwin
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S511 - S512
  • [5] Venous thromboembolism in Asian patients with inflammatory bowel disease
    Lin, H.
    Lim, W. C.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S311 - S312
  • [6] Risk of Venous Thromboembolism in Patients with Inflammatory Bowel Disease
    Koutroumpakis, Efstratios I.
    Tsiolakidou, Georgia
    Koutroubakis, Ioannis E.
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2013, 39 (05): : 461 - 468
  • [7] Venous thromboembolism in inflammatory bowel disease
    Kimberly Cheng
    Adam S Faye
    World Journal of Gastroenterology, 2020, 26 (12) : 1231 - 1241
  • [8] Venous thromboembolism with inflammatory bowel disease
    Mouelhi, L.
    Daboussi, O.
    Ben Khelifa, M.
    Houissa, F.
    El Jery, K.
    Said, Y.
    Salem, M.
    Dabbech, R.
    Najjar, T.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S173 - S173
  • [9] Venous thromboembolism with inflammatory bowel disease
    Hugh James Freeman
    World Journal of Gastroenterology, 2008, (07) : 991 - 993
  • [10] Venous thromboembolism in inflammatory bowel disease
    Cheng, Kimberly
    Faye, Adam S.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2020, 26 (12) : 1231 - 1241